Zealand Pharma A/S Capital Reinvestment Ratio
Zealand Pharma A/S capital reinvestment ratio. Zealand Pharma A/S (ZEAL) has a Capital Reinvestment Ratio of 0.00x as of June 2025, meaning it reinvests 0% of its operating cash flow (Dkr8.52 Billion) in capital expenditures (Dkr6.73 Million). Check Zealand Pharma A/S (ZEAL) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Zealand Pharma A/S (2012–2025)
Capital reinvestment ratio of Zealand Pharma A/S from 2012 to 2025. This chart tracks Zealand Pharma A/S's Capital Reinvestment Ratio across 3 annual periods. Also explore ZEAL net assets growth trend to track the company's year-over-year net asset growth rate.
Zealand Pharma A/S Capital Reinvestment Ratio by Year (2012–2025)
Zealand Pharma A/S capital reinvestment ratio by year from 2012 to 2025. For the full cash flow conversion analysis, see cash efficiency ratio of Zealand Pharma A/S.
| Year | Reinvestment Ratio | Operating CF (DKK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.01x | Dkr6.53 Billion | Dkr33.37 Million | ▼ -92.0% |
| 2016 | 0.06x | Dkr40.90 Million | Dkr2.60 Million | ▼ -50.8% |
| 2012 | 0.13x | Dkr68.54 Million | Dkr8.85 Million | — |